EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gut microbial metabolite 4-hydroxybenzeneacetic acid drives colorectal cancer progression via accumulation of immunosuppressive PMN-MDSCs

Qing Liao, Ximing Zhou, Ling Wu, Yuyi Yang, Xiaohui Zhu, Hangyu Liao, Yujie Zhang, Weidong Lian, Feifei Zhang, Hui Wang, Yanqing Ding, Liang Zhao

Journal of Clinical Investigation · 02.06.2025 · 135 (11)

DOI: 10.1172/jci181243 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 03.04.2025. Verfasst von Qing Liao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Shunde Hospital of Southern Medical University, Foshan, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Gastrointestinal Microbiome, Tumor Microenvironment, Myeloid-Derived Suppressor Cells. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Noncommunicable Chronic Diseases-National Science and Technology Major Project, National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is characterized by an immune-suppressive microenvironment that contributes to tumor progression and immunotherapy resistance. The gut microbiome produces diverse metabolites that feature unique mechanisms of interaction with host targets, yet the role of many metabolites in CRC remains poorly understood. In this study, the microbial metabolite 4-hydroxybenzeneacetic acid (4-HPA) promoted the infiltration of PMN myeloid-derived suppressor cells (PMN-MDSCs) in the tumor microenvironment, consequently inhibiting the antitumor response of CD8 + T cells and promoting CRC progression in vivo. Mechanistically, 4-HPA activates the JAK2/STAT3 pathway, which upregulates CXCL3 transcription, thereby recruiting PMN-MDSCs to the CRC microenvironment. Selective knockdown of CXCL3 resensitized tumors to anti-PD-1 immunotherapy in vivo. Chlorogenic acid reduces the production of 4-HPA by microbiota, likewise abolishing 4-HPA–mediated immunosuppression. The 4-HPA content in CRC tissues was notably increased in patients with advanced CRC. Overall, the gut microbiome uses 4-HPA as a messenger to control chemokine-dependent accumulation of PMN-MDSC cells and regulate antitumor immunity in CRC. Our findings provide a scientific basis for establishing clinical intervention strategies to reverse the tumor immune microenvironment and improve the efficacy of immunotherapy by reducing the interaction among intestinal microbiota, tumor cells, and tumor immune cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsGastrointestinal MicrobiomeTumor MicroenvironmentMyeloid-Derived Suppressor CellsPhenylacetatesAnimalsHumansMiceFemaleMaleCD8-Positive T-LymphocytesMice, Inbred C57BLCell Line, TumorNeutrophilsDisease Progression

Stichwörter der Autor:innen

Cancer immunotherapyColorectal cancerGastroenterologyImmunologyOncology

Substanzen

Phenylacetates

Autor:innen und Institutionen

  • Department of Pathology, Shunde Hospital of Southern Medical University, Foshan, China.
  • Department of Pathology & Guangdong Province Key Laboratory of Molecular Tumor Pathology, Basic Medical College, Southern Medical University, Guangzhou, China.
  • Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Department of Plastic and Aesthetic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Department of Medical Oncology, Affiliated Tumour Hospital of Guangzhou Medical University, Guangzhou, China.

Förderung

  • Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • National Natural Science Foundation of China
  • Guangdong Basic and Applied Basic Research Foundation
  • China Postdoctoral Science Foundation

Zitieren

APA

Liao, Q., Zhou, X., Wu, L., Yang, Y., Zhu, X., Liao, H., Zhang, Y., Lian, W., Zhang, F., Wang, H., Ding, Y., & Zhao, L. (2025). Gut microbial metabolite 4-hydroxybenzeneacetic acid drives colorectal cancer progression via accumulation of immunosuppressive PMN-MDSCs. Journal of Clinical Investigation, 135(11). https://doi.org/10.1172/jci181243

Vancouver

Liao Q, Zhou X, Wu L, Yang Y, Zhu X, Liao H, et al. Gut microbial metabolite 4-hydroxybenzeneacetic acid drives colorectal cancer progression via accumulation of immunosuppressive PMN-MDSCs. Journal of Clinical Investigation. 2025;135(11). doi:10.1172/jci181243

BibTeX
@article{Liao2025,
  author = {Liao, Qing and Zhou, Ximing and Wu, Ling and Yang, Yuyi and Zhu, Xiaohui and Liao, Hangyu and Zhang, Yujie and Lian, Weidong and Zhang, Feifei and Wang, Hui and Ding, Yanqing and Zhao, Liang},
  title = {Gut microbial metabolite 4-hydroxybenzeneacetic acid drives colorectal cancer progression via accumulation of immunosuppressive PMN-MDSCs},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  volume = {135},
  number = {11},
  doi = {10.1172/jci181243}
}
Kostenlos starten →